Cited by 552Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and OutcomesSmoking Behavior and Cessation

The DOI matches its Crossref record; 340 of the 341 references it cites were found in a registry or an index.

Cannabis use and cannabis use disorder

Open access

Connor, Jason P., Stjepanović, Daniel, Le Foll, Bernard, Hoch, Eva, Budney, Alan J., Hall, Wayne D.·2021·Nature Reviews Disease Primers

DOI 10.1038/s41572-021-00247-4PMC PMC8655458

Open this paper in CoChat — free account

Abstract

Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects ~10% of the 193 million cannabis users worldwide. The individual and public health burdens are less than those of other forms of drug use, but CUD accounts for a substantial proportion of persons seeking treatment for drug use disorders owing to the high global prevalence of cannabis use. Cognitive behavioural therapy, motivational enhancement therapy and contingency management can substantially reduce cannabis use and cannabis-related problems, but enduring abstinence is not a common outcome. No pharmacotherapies have been approved for cannabis use or CUD, although a number of drug classes (such as cannabinoid agonists) have shown promise and require more rigorous evaluation. Treatment of cannabis use and CUD is often complicated by comorbid mental health and other substance use disorders. The legalization of non-medical cannabis use in some high-income countries may increase the prevalence of CUD by making more potent cannabis products more readily available at a lower price. States that legalize medical and non-medical cannabis use should inform users about the risks of CUD and provide information on how to obtain assistance if they develop cannabis-related mental and/or physical health problems.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41572-021-00247-4

Cites

340 of 340 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Neurocircuitry of Addiction
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI)
Kessler, R. C., & Üstün, T. B. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.168 · Cited by 4,771
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Timeline Follow-Back
Sobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110
ADOLESCENT RESILIENCE: A Framework for Understanding Healthy Development in the Face of Risk
Fergus, S., & Zimmerman, M. A. (2004) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.26.021304.144357 · Cited by 3,243
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
The Neural Basis of Addiction: A Pathology of Motivation and Choice
Kalivas, P. W., & Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1403 · Cited by 2,757
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.6358 · Cited by 2,169
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin
Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 2,047
The hippocampal-VTA loop: controlling the entry of information into long-term memory
Lisman, J. E., & Grace, A. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.002 · Cited by 1,983
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility
Group, W. A. W. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00185.x · Cited by 1,982
Alcohol: No Ordinary Commodity. Research and public policy
Babor, T. F., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J. W., Hill, L., Holder, H. D., Homel, R. J., et al. (2003) · Cited by 1,718
DSM-5 criteria for substance use disorders: recommendations and rationale
Hasin, D. S., O’Brien, C. P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A., Compton, W. M., Crowley, T., Ling, W., Petry, N. M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12060782 · Cited by 1,622
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Degenhardt, L., Charlson, F., Ferrari, A., Santomauro, D., Erskine, H., Mantilla-Herrara, A., Whiteford, H., Leung, J., Naghavi, M., Griswold, M., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30337-7 · Cited by 1,572
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey
Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.2.3.244 · Cited by 1,341
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
European Monitoring Centre for Drugs and Drug Addiction
Anderson, M. (2014) · European Union regulations | European Encyclopedia of law · Cited by 1,214
Chemical constituents of marijuana: The complex mixture of natural cannabinoids
ElSohly, M. A., & Slade, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.011 · Cited by 1,094
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report
Peacock, A., Leung, J., Larney, S., Colledge‐Frisby, S., Hickman, M., Rehm, J. T., Giovino, G. A., West, R., Hall, W., Griffiths, P., et al. (2018) · Addiction · doi:10.1111/add.14234 · Cited by 1,093
Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013.
Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1858 · Cited by 1,086
Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor Mechanism
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,085
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., Rodriguez, V., Jongsma, H. E., Ferraro, L., La Cascia, C., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30048-3 · Cited by 875
Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens.
Pontieri, F. E., Tanda, G., & Chiara, G. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12304 · Cited by 868
Theory of Addiction
West, R., & Brown, J. (2013) · doi:10.1002/9781118484890 · Cited by 816
Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO world mental health surveys
Degenhardt, L., Chiu, W.-T., Sampson, N., Kessler, R. C., Anthony, J. C., Angermeyer, M., Bruffaerts, R., de Girolamo, G., Gureje, O., Huang, Y., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050141 · Cited by 796
Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders
Reed, G. M., First, M. B., Kogan, C. S., Hyman, S. E., Gureje, O., Gaebel, W., Maj, M., Stein, D. J., Maercker, A., Tyrer, P., et al. (2019) · World Psychiatry · doi:10.1002/wps.20611 · Cited by 765
Comparison of extended versus brief treatments for marijuana use.
Stephens, R. S., Roffman, R. A., & Curtin, L. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.5.898 · Cited by 711
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
Deutsch, D. G., & Chin, S. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90486-g · Cited by 706
Cognitive-Behavioral Treatment With Adult Alcohol and Illicit Drug Users: A Meta-Analysis of Randomized Controlled Trials
Magill, M., & Ray, L. A. (2009) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2009.70.516 · Cited by 694
Acute and Chronic Effects of Cannabinoids on Human Cognition—A Systematic Review
Broyd, S. J., van Hell, H. H., Beale, C., Yücel, M., & Solowij, N. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.12.002 · Cited by 674
Escalation of Drug Use in Early-Onset Cannabis Users vs Co-twin Controls
Lynskey, M. T., Heath, A. C., Bucholz, K. K., Slutske, W. S., Madden, P. A. F., Nelson, E. C., Statham, D. J., & Martin, N. G. (2003) · JAMA · doi:10.1001/jama.289.4.427 · Cited by 656
Stages and Pathways of Drug Involvement
Kandel, D. B. (2002) · Cambridge University Press eBooks · doi:10.1017/cbo9780511499777 · Cited by 601
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
Hirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.82 · Cited by 587
Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions–III
Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, S. M., Jung, J., Zhang, H., & Grant, B. F. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15070907 · Cited by 579
US epidemiology of cannabis use and associated problems
Hasin, D. S. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.198 · Cited by 578
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability
Pasman, J. A., Verweij, K. J. H., Gerring, Z. F., Stringer, S., Sanchez‐Roige, S., Treur, J. L., Abdellaoui, A., Nivard, M. G., Baselmans, B. M. L., Ong, J., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0206-1 · Cited by 505
Social and behavioral consequences of alcohol consumption and expectancy: A meta-analysis.
Hull, J. G., & Bond, C. F. (1986) · Psychological Bulletin · doi:10.1037/0033-2909.99.3.347 · Cited by 502
Differential control over cocaine-seeking behavior by nucleus accumbens core and shell
Ito, R., Robbins, T. W., & Everitt, B. J. (2004) · Nature Neuroscience · doi:10.1038/nn1217 · Cited by 501
Blockade of Effects of Smoked Marijuana by the CB1-Selective Cannabinoid Receptor Antagonist SR141716
Huestis, M. A., Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T., & Frank, R. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.322 · Cited by 497
Early onset cannabis use and psychosocial adjustment in young adults
Fergusson, D. M., & Horwood, L. J. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb03198.x · Cited by 493
Clinical calibration of DSM‐IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMH‐CIDI)
Kessler, R. C., Abelson, J., Demler, O., Escobar, J. I., Gibbon, M., Guyer, M. E., Howes, M. J., Jin, R., Vega, W. A., Walters, E. E., et al. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.169 · Cited by 489
Endocannabinoid signalling in reward and addiction
Parsons, L. H., & Hurd, Y. L. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn4004 · Cited by 488
Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis
Fergusson, D. M., Boden, J. M., & Horwood, L. J. (2006) · Addiction · doi:10.1111/j.1360-0443.2005.01322.x · Cited by 484
Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis
Hunt, G. E., Large, M. M. B., Cleary, M. L., Lai, H. M. X., & Saunders, J. B. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.011 · Cited by 483
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Foll, B. L., Hall, W., Rehm, J. T., & Room, R. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303818 · Cited by 474
The time course and significance of cannabis withdrawal.
Budney, A. J., Moore, B. A., Vandrey, R. G., & Hughes, J. R. (2003) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.112.3.393 · Cited by 453
The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research
Bossert, J. M., Marchant, N. J., Calu, D. J., & Shaham, Y. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3120-y · Cited by 453
Addictive drugs as reinforcers: multiple partial actions on memory systems
WHITE, N. M. (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb03586.x · Cited by 439
Prevention, early intervention, harm reduction, and treatment of substance use in young people
Stockings, E., Hall, W. D., Lynskey, M., Morley, K. I., Reavley, N., Strang, J., Patton, G., & Degenhardt, L. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00002-x · Cited by 433
Proof of Concept Trial of Dronabinol in Obstructive Sleep Apnea
Prasad, B., Radulovacki, M. G., & Carley, D. W. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00001 · Cited by 424
The effects of Δ9-tetrahydrocannabinol on the dopamine system
Bloomfield, M., Ashok, A. H., Volkow, N. D., & Howes, O. D. (2016) · Nature · doi:10.1038/nature20153 · Cited by 400
Transitions from first substance use to substance use disorders in adolescence: Is early onset associated with a rapid escalation?
Behrendt, S., Wïttchen, H., Höfler, M., Lieb, R., & Beesdo, K. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.06.014 · Cited by 396
Keep off the grass? Cannabis, cognition and addiction
Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J. A., & Parsons, L. H. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.28 · Cited by 389
Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine.
Wagner, F. A. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.10.918 · Cited by 380
Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys
Compton, W. M., Han, B., Jones, C. M., Blanco, C., & Hughes, A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30208-5 · Cited by 377
Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic Review
Sorensen, C. J., DeSanto, K., Borgelt, L. M., Phillips, K. T., & Monte, A. A. (2016) · Journal of Medical Toxicology · doi:10.1007/s13181-016-0595-z · Cited by 374
Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state
Smart, R., Caulkins, J. P., Kilmer, B., Davenport, S., & Midgette, G. (2017) · Addiction · doi:10.1111/add.13886 · Cited by 371
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Busquets-García, A., Bains, J. S., & Marsicano, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.206 · Cited by 365
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use
Hall, W., Stjepanović, D., Caulkins, J., Lynskey, M., Leung, J., Campbell, G., & Degenhardt, L. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31789-1 · Cited by 357
Behavioral medicine : changing health lifestyles
Davidson, P. O., & Davidson, S. M. (1980) · Brunner/Mazel eBooks · Cited by 351
Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances--systematic review and meta-analysis.
Hjorthøj, C., Hjorthøj, A. R., & Nordentoft, M. (2012) · Addictive Behaviours · doi:10.1016/j.addbeh.2011.11.025 · Cited by 349
Marijuana withdrawal among adults seeking treatment for marijuana dependence.
Budney, A. J., Novy, P. L., & Hughes, J. R. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.94913114.x · Cited by 348
Clinical correlates of co‐occurring cannabis and tobacco use: a systematic review
Peters, E. N., Budney, A. J., & Carroll, K. M. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03843.x · Cited by 333
The effects of cannabis intoxication on motor vehicle collision revisited and revised
Røgeberg, O. J., & Elvik, R. (2016) · Addiction · doi:10.1111/add.13347 · Cited by 330
Cannabinoid Hyperemesis: A Case Series of 98 Patients
Simonetto, D. A., Oxentenko, A. S., Herman, M. L., & Szostek, J. H. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.10.005 · Cited by 327
The Comparative Effectiveness of Outpatient Treatment for Adolescent Substance Abuse: A Meta-Analysis
Tanner-Smith, E., Wilson, S., & Lipsey, M. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2012.05.006 · Cited by 316
The Role of Risk and Protective Factors in Substance Use Across Adolescence
Cleveland, M. J., Feinberg, M. E., Bontempo, D. E., & Greenberg, M. T. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2008.01.015 · Cited by 312
The developmental antecedents of illicit drug use: Evidence from a 25-year longitudinal study
Fergusson, D. M., Boden, J. M., & Horwood, L. J. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.03.003 · Cited by 308
A Double-Blind Randomized Controlled Trial of N -Acetylcysteine in Cannabis-Dependent Adolescents
Gray, K. M., Carpenter, M. J., Baker, N. L., DeSantis, S. M., Kryway, E., Hartwell, K. J., McRae-Clark, A. L., & Brady, K. T. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010055 · Cited by 306
What predicts incident use of cannabis and progression to abuse and dependence?
von Sydow, K., Lieb, R., Pfister, H., Höfler, M., & Wittchen, H.-U. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00102-3 · Cited by 301
Reassessing the marijuana gateway effect
Morral, A. R., McCaffrey, D. F., & Paddock, S. M. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00280.x · Cited by 296
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
Foll, B. L., & Goldberg, S. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 294
Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence.
Budney, A. J., Moore, B. A., Rocha, H. L., & Higgins, S. T. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.4.2.307 · Cited by 290
Self-citation
Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990–2019: Systematic review and meta-analysis
Hunt, G. E., Malhi, G. S., Lai, H. M. X., & Cleary, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.141 · Cited by 289
A Sociocognitive Analysis of Substance Abuse: An Agentic Perspective
Bandura, A. (1999) · Psychological Science · doi:10.1111/1467-9280.00138 · Cited by 282
Psychosocial interventions for cannabis use disorder
Gates, P. J., Sabioni, P., Copeland, J., Le Foll, B., & Gowing, L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005336.pub4 · Cited by 282
Cannabis Addiction and the Brain: a Review
Zehra, A., Burns, J. A., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9782-9 · Cited by 277
The effects of fifteen evidence-supported therapies for adult depression: A meta-analytic review
Cuijpers, P., Karyotaki, E., de Wit, L., & Ebert, D. D. (2020) · Psychotherapy Research · doi:10.1080/10503307.2019.1649732 · Cited by 276
Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction
Lupica, C. R., & Riegel, A. C. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.016 · Cited by 268
Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs
Hall, W., & Lynskey, M. T. (2005) · Drug and Alcohol Review · doi:10.1080/09595230500126698 · Cited by 267
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial
Allsop, D. J., Copeland, J., Lintzeris, N., Dunlop, A. J., Montebello, M., Sadler, C., Rivas, G. R., Holland, R. M., Muhleisen, P., Norberg, M. M., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3947 · Cited by 266
Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Curry, S. J., Donahue, K., Doubeni, C. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.8020 · Cited by 266
Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex
Haney, M., Hart, C. L., Vosburg, S. K., Nasser, J. A., Bennett, A., Zúbaran, C., & Foltin, R. W. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300310 · Cited by 264
Internet-delivered health interventions that work: systematic review of meta-analyses and evaluation of website availability
Rogers, M. A., Lemmen, K., Kramer, R., Mann, J., & Chopra, V. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7111 · Cited by 259
Genetic and environmental influences on cannabis use initiation and problematic use: a meta‐analysis of twin studies
Verweij, K. J. H., Zietsch, B. P., Lynskey, M. T., Medland, S. E., Neale, M. C., Martin, N. G., Boomsma, D. I., & Vink, J. M. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02831.x · Cited by 254
Clinical effectiveness and cost-effectiveness of open and arthroscopic rotator cuff repair [the UK Rotator Cuff Surgery (UKUFF) randomised trial]
Carr, A. J., Cooper, C., Campbell, M., Rees, J. L., Moser, J. S., Beard, D. J., Fitzpatrick, R. M., Gray, A. M., Dawson, J., Murphy, J., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19800 · Cited by 249
The neuropsychopharmacology of cannabis: A review of human imaging studies
Bloomfield, M., Hindocha, C., Green, S. F., Wall, M. B., Lees, R., Petrilli, K., Costello, H., Ogunbiyi, O., Bossong, M. G., & Freeman, T. P. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.006 · Cited by 247
Effects of the National Youth Anti-Drug Media Campaign on Youths
Hornik, R., Jacobsohn, L. S., Orwin, R. G., Piesse, A., & Kalton, G. (2008) · American Journal of Public Health · doi:10.2105/ajph.2007.125849 · Cited by 243
A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.
Mason, B. J., Crean, R., Goodell, V., Light, J. M., Quello, S., Shadan, F., Buffkins, K., Kyle, M., Adusumalli, M., Begovic, A., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.14 · Cited by 242
The adverse health effects of chronic cannabis use
Hall, W., & Degenhardt, L. J. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1506 · Cited by 235
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.
Levin, F. R., Mariani, J. J., Brooks, D. J., Pavlicova, M., Cheng, W., & Nunes, E. V. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.12.010 · Cited by 232
Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models
Zahr, N. M. (2017) · Alcohol research · doi:10.35946/arcr.v38.2.04 · Cited by 231
Alcohol- and Drug-Use Disorders in Australia: Implications of the National Survey of Mental Health and Wellbeing
Teesson, M., Hall, W., Lynskey, M. T., & Degenhardt, L. J. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2000.00715.x · Cited by 230
Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity
Volkow, N. D., Wang, G., Telang, F., Fowler, J. S., Alexoff, D. L., Logan, J., Jayne, M. C., Wong, C., & Tomasi, D. G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411228111 · Cited by 230
The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: Reliability, validity and diagnostic cut-off
Martin, G., Copeland, J., Gates, P., & Gilmour, S. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.10.014 · Cited by 229
‘Standard THC units’: a proposal to standardize dose across all cannabis products and methods of administration
Freeman, T. P., & Lorenzetti, V. (2019) · Addiction · doi:10.1111/add.14842 · Cited by 222
Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study
Toftdahl, N. G., Nordentoft, M., & Hjorthøj, C. R. (2015) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-015-1104-4 · Cited by 217
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Bloomfield, M., Morgan, C. J. A., Egerton, A., Kapur, S., Curran, H. V., & Howes, O. D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.027 · Cited by 215
The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence
Carroll, K. M., Easton, C. J., Nich, C., Hunkele, K. A., Neavins, T. M., Sinha, R., Ford, H. L., Vitolo, S. A., Doebrick, C. A., & Rounsaville, B. J. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.5.955 · Cited by 214
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Freeman, T. P., Hindocha, C., Baio, G., Shaban, N. D. C., Thomas, E. M., Astbury, D., Freeman, A. M., Lees, R., Craft, S., Morrison, P. D., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30290-x · Cited by 211
The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress
Allsop, D. J., Norberg, M. M., Copeland, J., Fu, S., & Budney, A. J. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.06.003 · Cited by 206
The adverse health effects of cannabis use: What are they, and what are their implications for policy?
Hall, W. (2009) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2009.02.013 · Cited by 206
Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis
D’Souza, D. C., Cortes-Briones, J., Ranganathan, M., Thurnauer, H., Creatura, G. M., Surti, T. S., Planeta, B. M., Neumeister, A., Pittman, B. P., Normandin, M. D., et al. (2015) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.09.008 · Cited by 204
Marijuana Legalization: What Everyone Needs to Know
Caulkins, J., Kilmer, B., & R.Kleiman, M. A. (2016) · Oxford University Press eBooks · doi:10.7249/cb525-1 · Cited by 198
Evidence Base on Outpatient Behavioral Treatments for Adolescent Substance Use, 2014–2017: Outcomes, Treatment Delivery, and Promising Horizons
Hogue, A., Henderson, C. E., Becker, S. J., & Knight, D. K. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2018.1466307 · Cited by 197
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial
D’Souza, D. C., Cortes-Briones, J., Creatura, G. M., Bluez, G., Thurnauer, H., Deaso, E., Forselius-Bielen, K., Surti, T. S., Radhakrishnan, R., Gupta, A., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30427-9 · Cited by 195
Individual-, family-, and school-level interventions targeting multiple risk behaviours in young people
MacArthur, G. J., Caldwell, D. M., Redmore, J., Watkins, S., Kipping, R., White, J., Chittleborough, C., Langford, R. M., Er, V., Lingam, R., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009927.pub2 · Cited by 185
Predicting the transition from frequent cannabis use to cannabis dependence: A three-year prospective study
van der Pol, P., Liebregts, N., de Graaf, R., Korf, D. J., van den Brink, W., & van Laar, M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.06.009 · Cited by 180
Respiratory and Immunologic Consequences of Marijuana Smoking
Tashkin, D. P., Baldwin, G. C., Sarafian, T. A., Dubinett, S. M., & Roth, M. D. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb06006.x · Cited by 179
The Marijuana Treatment Project: rationale, design and participant characteristics
Stephens, R. S., Babor, T. F., Kadden, R., Miller, M., & The Marijuana Treatment Project Research Group (2002) · Addiction · doi:10.1046/j.1360-0443.97.s01.6.x · Cited by 178
Alcohol- and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing
Teesson, M., Hall, W., Lynskey, M. T., & Degenhardt, L. J. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00715.x · Cited by 176
Abstinence rates following behavioral treatments for marijuana dependence
Kadden, R. M., Litt, M. D., Kabela-Cormier, E., & Petry, N. M. (2007) · Addictive Behaviors · doi:10.1016/j.addbeh.2006.08.009 · Cited by 173
Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks
Sherva, R., Wang, Q., Kranzler, H. R., Zhao, H., Koesterer, R., Herman, A. I., Farrer, L. A., & Gelernter, J. E. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0036 · Cited by 170
Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9‐Tetrahydrocannabinol‐Tolerant Rats
Marzo, V. D., Berrendero, F., Bisogno, T., González, S. R., Cavaliere, P., Romero, J., Cebeira, M., Ramos, J. A., & Fernández‐Ruíz, J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741627.x · Cited by 167
Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence
Lorenzetti, V., Hoch, E., & Hall, W. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.03.012 · Cited by 166
Self-citation
Choosing a diagnostic cut‐off for cannabis dependence
Swift, W., Copeland, J., & Hall, W. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.931116816.x · Cited by 165
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users
Huestis, M. A., Boyd, S. J., Heishman, S. J., Preston, K. L., BONNET, D., Fur, G. L., & Gorelick, D. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0861-5 · Cited by 165
The importance of considering polysubstance use: lessons from cocaine research
Liu, Y., Williamson, V. G., Setlow, B., Cottler, L. B., & Knackstedt, L. A. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.025 · Cited by 165
Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium
Stringer, S., Minică, C. C., Verweij, K. J. H., Mbarek, H., Bernard, M., Derringer, J. L., van Eijk, K. R., Isen, J. D., Loukola, A., Maciejewski, D. F., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.36 · Cited by 160
Adolescent precursors of cannabis dependence: findings from the Victorian Adolescent Health Cohort Study
Coffey, C., Carlin, J. B., Lynskey, M. T., Li, N., & Patton, G. C. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.182.4.330 · Cited by 157
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Gray, K. M., Sonne, S. C., McClure, E. A., Ghitza, U. E., Matthews, A. G., McRae-Clark, A. L., Carroll, K. M., Potter, J. S., Wiest, K., Mooney, L. J., et al. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.04.020 · Cited by 157
Pharmacotherapies for cannabis dependence.
Marshall, K., Gowing, L., Ali, R., & Le Foll, B. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008940.pub2 · Cited by 156
Trends in Reported Marijuana Vaping Among US Adolescents, 2017-2019
Miech, R. A., Patrick, M. E., O’Malley, P. M., Johnston, L. D., & Bachman, J. G. (2019) · JAMA · doi:10.1001/jama.2019.20185 · Cited by 154
Cannabis and Psychosis: a Critical Overview of the Relationship
Ksir, C., & Hart, C. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-015-0657-y · Cited by 153
Cannabis Use and Dependence
Hall, W., & Pacula, R. L. (2002) · Cambridge University Press eBooks · doi:10.1017/cbo9780511470219 · Cited by 152
Neurocognitive consequences of chronic cannabis use: a systematic review and meta-analysis
Figueiredo, P. R., Tolomeo, S., Steele, J. D., & Baldacchino, A. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.014 · Cited by 149
The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal
Brezing, C., & LEVIN, F. R. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.212 · Cited by 148
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum
Bossong, M. G., Mehta, M. A., van Berckel, B. N. M., Howes, O. D., Kahn, R. S., & Stokes, P. R. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3915-0 · Cited by 143
Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids
Bahji, A., Stephenson, C., Tyo, R., Hawken, E. R., & Seitz, D. P. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2370 · Cited by 139
Deficits in striatal dopamine release in cannabis dependence
van de Giessen, E., Weinstein, J. J., Cassidy, C., Haney, M., Dong, Z., Ghazzaoui, R., Ojeil, N., Kegeles, L. S., Xu, X., Vadhan, N. P., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.21 · Cited by 136
The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018
Cox, C. M. (2018) · Health Policy · doi:10.1016/j.healthpol.2018.01.009 · Cited by 135
Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse
Haney, M., Cooper, Z. D., Bedi, G., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.54 · Cited by 134
The Insula: A Brain Stimulation Target for the Treatment of Addiction
Ibrahim, C., Rubin-Kahana, D. S., Pushparaj, A., Musiol, M., Blumberger, D. M., Daskalakis, Z. J., Zangen, A., & Le Foll, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00720 · Cited by 133
Heavy cannabis use, dependence and the brain: a clinical perspective
Kroon, E., Kuhns, L., Hoch, E., & Cousijn, J. (2019) · Addiction · doi:10.1111/add.14776 · Cited by 133
High times for cannabis: Epigenetic imprint and its legacy on brain and behavior
Szutorisz, H., & Hurd, Y. L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.011 · Cited by 131
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., Hasan, A., & Pogarell, O. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00984-4 · Cited by 131
Self-citation
State of the Art Treatments for Cannabis Dependence
Danovitch, I., & Gorelick, D. A. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.03.003 · Cited by 129
Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life
Hser, Y.-I., Mooney, L. J., Huang, D., Zhu, Y., Tomko, R. L., McClure, E., Chou, C.-P., & Gray, K. M. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.07.012 · Cited by 127
Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys.
Wiley, J. L., Lowe, J. A., III, Balster, R. L., & Martin, B. R. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12022-3 · Cited by 126
Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies
Lorenzetti, V., Chye, Y., Silva, P., Solowij, N., & Roberts, C. A. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00979-1 · Cited by 125
Effect of oxytocin on craving and stress response in marijuana-dependent individuals: A pilot study
McRae-Clark, A. L., Baker, N. L., Maria, M. M.-S., & Brady, K. T. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3062-4 · Cited by 124
DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles
Kerridge, B. T., Pickering, R. P., Chou, P. S., Saha, T. D., & Hasin, D. S. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.07.012 · Cited by 122
Gender differences in health-related quality of life among cannabis users: Results from the national epidemiologic survey on alcohol and related conditions
Lev‐Ran, S., Imtiaz, S., Taylor, B. J., Shield, K. D., Rehm, J. T., & Foll, B. L. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.11.010 · Cited by 121
Dopamine Release in Chronic Cannabis Users: A [11C]Raclopride Positron Emission Tomography Study
Urban, N., Slifstein, M., Thompson, J. L., Xu, X., Girgis, R. R., Raheja, S., Haney, M., & Abi‐Dargham, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.018 · Cited by 119
Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands
Freeman, T. P., van der Pol, P., Kuijpers, W., Wisselink, J., Das, R., Rigter, S., van Laar, M., Griffiths, P., Swift, W., Niesink, R. J. M., et al. (2018) · Psychological Medicine · doi:10.1017/s0033291717003877 · Cited by 119
A meta-analytic review of school-based prevention for cannabis use
Porath-Waller, A. J., Beasley, E., & Beirness, D. J. (2010) · Health Education & Behavior · doi:10.1177/1090198110361315 · Cited by 118
How and why have attitudes about cannabis legalization changed so much?
Felson, J., Adamczyk, A., & Thomas, C. (2018) · Social Science Research · doi:10.1016/j.ssresearch.2018.12.011 · Cited by 116
Prevalence of Cannabis Use in Youths After Legalization in Washington State
Dilley, J. A., Richardson, S. M., Kilmer, B., Pacula, R. L., Segawa, M. B., & Cerdá, M. (2018) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2018.4458 · Cited by 115
Behavioral Therapies for Treatment-Seeking Cannabis Users: A Meta-Analysis of Randomized Controlled Trials
Davis, M. L., Powers, M. B., Handelsman, P., Medina, J. L., Zvolensky, M., & Smits, J. A. J. (2015) · Evaluation & the Health Professions · doi:10.1177/0163278714529970 · Cited by 114
An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use
Budney, A. J., Sofis, M. J., & Borodovsky, J. T. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0976-1 · Cited by 113
Cannabis use and suicide attempts among 86,254 adolescents aged 12–15 years from 21 low- and middle-income countries
Carvalho, A. F., Stubbs, B., Vancampfort, D., Kloiber, S. M., Maes, M. H. J., Firth, J., Kurdyak, P. A., Stein, D. J., Rehm, J. T., & Koyanagi, A. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.10.006 · Cited by 112
Reinforcement processes in opiate addiction: A homeostatic model
Schulteis, G., & Koob, G. F. (1996) · Neurochemical Research · doi:10.1007/bf02532385 · Cited by 111
The opioid antagonist naltrexone reduces the reinforcing effects of ? 9 -tetrahydrocannabinol (THC) in squirrel monkeys
Tanda, G., Munzar, P., Goldberg, S. R., & Justinova, Z. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1693-6 · Cited by 111
Short- and long-term effects of digital prevention and treatment interventions for cannabis use reduction: A systematic review and meta-analysis
Boumparis, N., Loheide-Niesmann, L., Blankers, M., Ebert, D. D., Korf, D., Schaub, M. P., Spijkerman, R., Tait, R. J., & Riper, H. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.03.016 · Cited by 110
A ‘standard joint’? The role of quantity in predicting cannabis-related problems
Zeisser, C., Thompson, K., Stockwell, T. R., Duff, C., Chow, C., Vallance, K., Ivsins, A., Michelow, W., Marsh, D. C., & Lucas, P. (2011) · Addiction Research & Theory · doi:10.3109/16066359.2011.569101 · Cited by 109
Pharmacotherapy for Cannabis Dependence
Vandrey, R. G., & Haney, M. (2009) · CNS Drugs · doi:10.2165/00023210-200923070-00001 · Cited by 109
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
Levin, F. R., Mariani, J. J., Pavlicova, M., Brooks, D., Glass, A., Mahony, A., Nunes, E. V., Bisaga, A., Dakwar, E., Carpenter, K. M., et al. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.11.025 · Cited by 109
The association between cannabis use and anxiety disorders: Results from a population-based representative sample
Feingold, D., Weiser, M., Rehm, J. T., & Lev‐Ran, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.037 · Cited by 109
Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017
Klieger, S. B., Gutman, A., Allen, L., Pacula, R. L., Ibrahim, J. K., & Burris, S. C. (2017) · Addiction · doi:10.1111/add.13910 · Cited by 107
Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms
Morgan, C. J. A., Page, E., Schaefer, C., Chatten, K., Manocha, A., Gulati, S., Curran, H. V., Brandner, B., & Leweke, F. M. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.121178 · Cited by 106
Vaporized Cannabis Extracts Have Reinforcing Properties and Support Conditioned Drug-Seeking Behavior in Rats
Freels, T. G., Baxter-Potter, L. N., Lugo, J. M., Glodosky, N. C., Wright, H. R., Baglot, S. L., Petrie, G. N., Yu, Z., Clowers, B. H., Cuttler, C., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2416-19.2020 · Cited by 105
The Effects of Cannabis Use on the Development of Adolescents and Young Adults
Hall, W., Leung, J., & Lynskey, M. T. (2020) · Annual Review of Developmental Psychology · doi:10.1146/annurev-devpsych-040320-084904 · Cited by 105
Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans
Foll, B. L., & Goldberg, S. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.005 · Cited by 102
A genome-wide association study of DSM-IV cannabis dependence
Arpana Agrawal, A., Lynskey, M. T., Hinrichs, A. L., Grucza, R. A., Saccone, S. F., Krueger, R. F., Neuman, R. J., Howells, W. A. B., Fisher, S. L., Fox, L. W., et al. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00255.x · Cited by 101
The Effectiveness of Psychosocial Modalities in the Treatment of Alcohol Problems in Adults: A Review of the Evidence
Martin, G. W., & Rehm, J. T. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700604 · Cited by 99
Brief school-based interventions and behavioural outcomes for substance-using adolescents
Carney, T., Myers, B. J., Louw, J., & Okwundu, C. I. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008969.pub3 · Cited by 99
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.
Trigo, J. M., Lagzdins, D., Rehm, J., Selby, P., Gamaleddin, I., Fischer, B., Barnes, A. J., Huestis, M. A., & Le Foll, B. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.02.020 · Cited by 97
Polysubstance Use in Cannabis Users Referred for Treatment: Drug Use Profiles, Psychiatric Comorbidity and Cannabis-Related Beliefs
Connor, J. P., Gullo, M. J., Chan, G., Young, R. M., Hall, W., & Feeney, G. F. X. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00079 · Cited by 96
Pharmacotherapies for cannabis dependence
Nielsen, S., Gowing, L., Sabioni, P., & Le Foll, B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008940.pub3 · Cited by 96
The Cannabis Problems Questionnaire: Factor structure, reliability, and validity
Copeland, J., Gilmour, S., Gates, P., & Swift, W. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.04.009 · Cited by 95
Current advances in the treatment of adolescent drug use
Winters, K. C., Tanner‐Smith, E. E., Bresani, E., & Meyers, K. (2014) · Adolescent Health Medicine and Therapeutics · doi:10.2147/ahmt.s48053 · Cited by 94
It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets
Salami, S. A., Martinelli, F., Giovino, A., Bachari, A., Arad, N., & Mantri, N. L. (2020) · Molecules · doi:10.3390/molecules25184036 · Cited by 92
Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high‐resolution PET study
Leroy, C., Karila, L., Martinot, J., Lukasiewicz, M., Duchesnay, É., Comtat, C., Dollé, F., Benyamina, A., Eric Artiges, A., Ribeiro, M. J., et al. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00356.x · Cited by 91
Does single parenthood increase the probability of teenage promiscuity, substance use, and crime?
Antecol, H., & Bedard, K. (2007) · Journal of Population Economics · doi:10.1007/s00148-005-0019-x · Cited by 91
Facilitators and barriers in treatment seeking for cannabis dependence
van der Pol, P., Liebregts, N., de Graaf, R., Korf, D. J., van den Brink, W., & van Laar, M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.08.011 · Cited by 91
Cannabis and schizophrenia
Mcloughlin, B. C., Pushpa-Rajah, J. A., Gillies, D. M., Rathbone, J., Variend, H., Kalakouti, E., & Kyprianou, K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004837.pub3 · Cited by 91
Cannabis Withdrawal: a Review of Neurobiological Mechanisms and Sex Differences
Schlienz, N. J., Budney, A. J., Lee, D. C., & Vandrey, R. G. (2017) · Current Addiction Reports · doi:10.1007/s40429-017-0143-1 · Cited by 91
Quality of Life Following Remission of Mental Disorders
Rubio, J. M., Olfson, M., Villegas, L., Pérez-Fuentes, G., Wang, S., & Blanc, C. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08269 · Cited by 90
Cannabis Use in Adolescence and Young Adulthood
Coffey, C., & Patton, G. C. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716645289 · Cited by 87
DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults
Livne, O., Shmulewitz, D., Lev‐Ran, S., & Hasin, D. S. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.09.005 · Cited by 87
How Medical Marijuana Smoothed the Transition to Marijuana Legalization in the United States
Kilmer, B., & MacCoun, R. J. (2017) · Annual Review of Law and Social Science · doi:10.1146/annurev-lawsocsci-110615-084851 · Cited by 86
Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review
Wilson, L., Szigeti, A., Kearney, A., & Clarke, M. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.11.001 · Cited by 86
Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health
Matheson, J., & Foll, B. L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.591979 · Cited by 85
Illicit Drug use and Dependence in a New Zealand Birth Cohort
Boden, J. M., Fergusson, D. M., & Horwood, L. J. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01763.x · Cited by 83
Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography
Sevy, S., Smith, G. S., Ma, Y., Dhawan, V., Chaly, T., Kingsley, P. B., Kumra, S., Abdelmessih, S., & Eidelberg, D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1075-1 · Cited by 83
The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression
Pinto, J. V., Medeiros, L. S., da Rosa, G. S., de Oliveira, C. E. S., Crippa, J. A. S., Passos, I. C., & Kauer‐Sant’Anna, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.004 · Cited by 83

Research works printed but not linked: 13

Hall, W., Renström, M. & Poznyak, V. The Health and Social Effects of Nonmedical Cannabis Use (World Health Organization, 2016). This is a seminal review of the short-term and long-term effects of cannabis use and CUD on health.
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, & Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (National Academies Press, 2017).
Compton, W. M. & Han, B. in The Complex Connection between Cannabis and Schizophrenia (eds Compton, M. & Manseau, M.) (Academic Press, 2017).
Connor, J. P., Feeney, G. F. X., Kelly, A. B. & Saunders, J. B. in The SAGE Handbook of Drug & Alcohol Studies. Volume 2, 283–305 (SAGE Publications, 2016).
Howlett, A. C. in Cannabinoids. Handbook of Experimental Psychology, vol 168 (ed. Pertwee, R. G.) 53–79. (Springer, 2005).
Trick, L. et al. in PET and SPECT in Psychiatry 2nd edn (eds Dierckx, R. A. J. O., Otte, A., de Vries, E. F. J., van Waarde, A. & Sommer, I. E.) 653–712 (Springer, 2020).
McMurran, M. The Psychology of Addiction (Routledge, 1994).
American Psychiatric Association. Substance-related and addictive disorders. in Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, 2013). · DOI · Paper page
Connor, J. P., Saunders, J. B. & Feeney, G. F. X. in Quality of Life in Mental Disorders (eds Katschnig, H., Freeman, H. L. & Sartorius, N.) 199–208 (John Wiley & Sons, 2006).
Longabaugh, R., Magill, M., Morgenstern, J. & Huebner, R. in Addictions: A Comprehensive Guidebook (eds McCrady, B. S. & Epstein, E. E.) 572–596 (Oxford University Press, 2013).
Marlatt, G. A., & Donovan, D. M. (eds) Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors (Guilford Press, 1985).
Saunders, J. B. et al. (eds) Addiction Medicine (Oxford University Press, 2016).
Ries, N. M. Prescribe with caution: the response of canada’s medical regulatory authorities to the therapeutic use of cannabis. McGill J. Law Health 9, 215–254 (2016).

Sorted by citations

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Solmi, M., Toffol, M. D., Kim, J. Y., Choi, M., Stubbs, B., Thompson, T., Firth, J., Miola, A., Croatto, G., Baggio, F., et al. (2023) · BMJ · doi:10.1136/bmj-2022-072348 · Cited by 322
Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
Tanaka, M., Tóth, F., Polyák, H., Szabó, Á., Mándi, Y., & Vécsei, L. (2021) · Biomedicines · doi:10.3390/biomedicines9070734 · Cited by 259
Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates
Manthey, J., Freeman, T. P., Kilian, C., López‐Pelayo, H., & Rehm, J. T. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100227 · Cited by 184
Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults
Mennis, J. L., McKeon, T. P., & Stahler, G. J. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107552 · Cited by 131
Therapeutic effect of psilocybin in addiction: A systematic review
van der Meer, P. B., Fuentes, J. J., Kaptein, A. A., Schoones, J. W., de Waal, M. M., Goudriaan, A. E., Kramers, K., Schellekens, A., Somers, M., Bossong, M. G., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1134454 · Cited by 127

See all 552

Authors: Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D.
Affiliations: The University of Queensland (AU)
LMU Klinikum (DE)
Dartmouth College (US)
Corresponding author: Connor, Jason P.
ORCID: Connor, Jason P.
Stjepanović, Daniel
Budney, Alan J.
Hall, Wayne D.
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2021-02-25
Volume: 7
Issue: 1
Pages: 16-16
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-021-00247-4
PMC: PMC8655458
OpenAlex: W3131397527
Cited by: 552
References: 341
Citations by year: 2026: 106 · 2025: 135 · 2024: 119 · 2023: 122 · 2022: 49 · 2021: 21
FWCI: 9.85
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Drug Abuse (R01DA050032, T32DA037202, P30DA029926)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords: cannabis use disorder, cannabis use, cognitive behavioral therapy, motivational enhancement therapy, contingency management, abstinence, cannabinoid receptor agonists, pharmacotherapy, psychiatric comorbidity, substance use disorders, cannabis legalization, medical cannabis, non-medical cannabis, public health burden
MeSH terms: Analgesics, Cannabis, Marijuana Abuse, Humans, Cognitive Behavioral Therapy, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabis use and cannabis use disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks